COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy

Keyphrases

• Ferritin 100%
• COVID-19 100%
• Iron Depletion Therapy 100%
• Hyperferritinemic Syndrome 100%
• SARS-CoV-2 Infection 66%
• Fibrosis 33%
• Novel Therapeutics 33%
• Viral 33%
• Clinical picture 33%
• Lymphopenia 33%
• Iron Chelation 33%
• Iron Overload 33%
• Interleukin-6 33%
• Inflammatory Process 33%
• Life-limiting Conditions 33%
• Immunomodulatory Effect 33%
• Septic Shock 33%
• Pathogenic Role 33%
• Free Iron 33%
• Redox 33%
• Cytokine Release 33%
• Severe COVID-19 Patients 33%
• Hemophagocytic Lymphohistiocytosis 33%
• Neutrophilia 33%
• Macrophage Activation Syndrome 33%
• COVID-19 Pandemic 33%
• Adult-onset Still's Disease 33%
• Antifibrotic 33%
• Pulmonary Involvement 33%
• Hyperferritinemia 33%
• Catastrophic Antiphospholipid Syndrome 33%

Medicine and Dentistry

• COVID-19 100%
• Iron Depletion 100%
• Ferritin 75%
• Infection 50%
• Severe Acute Respiratory Syndrome Coronavirus 2 50%
• Disease 25%
• Fibrosis 25%
• Serositis 25%
• Hyperferritinemia 25%
• Iron Overload 25%
• Cytokine Release 25%
• Antivirus Agent 25%
• Interleukin-6 25%
• Lymphocytopenia 25%
• Hemophagocytic Syndrome 25%
• Septic Shock 25%
• Neutrophilia 25%
• Catastrophic Antiphospholipid Syndrome 25%
• Macrophage Activation Syndrome 25%
• Adult Onset Still Disease 25%